The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.06
Bid: 14.90
Ask: 15.02
Change: -0.12 (-0.79%)
Spread: 0.12 (0.805%)
Open: 15.00
High: 15.06
Low: 14.70
Prev. Close: 15.18
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations update

12 May 2021 07:00

RNS Number : 2980Y
EnQuest PLC
12 May 2021
 

 

EnQuest PLC, 12 May 2021

Operations update

Full year 2021 guidance remains unchanged

 

EnQuest Chief Executive, Amjad Bseisu, said:

"EnQuest remains on track to deliver against its targets. Performance at Kraken has been strong, with the FPSO continuing to perform well, and production at PM8/Seligi has improved following the completion of initial restoration activities ahead of schedule. While Magnus performance has been below expectations, we have a number of activities planned for the rest of the year to optimise production.

"We have continued to pursue opportunities to enhance our portfolio with our agreements to acquire the Golden Eagle and Bentley assets. Golden Eagle will add immediate material production, reserves and cash flow to the Group, while Bentley offers further long-term potential development opportunities and other synergies to add to those at Bressay.

"The various workstreams in relation to the Golden Eagle acquisition continue on track and operationally we are focused on improving production across our portfolio."

Operating performance

§ Average net Group production in the four months to end April 2021 was 46,158 Boepd, within the Group's full year 2021 guidance range which remains unchanged at between 46,000 and 52,000 Boepd (net)

§ Strong production at Kraken and PM8/Seligi reflects high production efficiency at both assets and the acceleration of well restoration activities at PM8/Seligi

§ Production at Magnus has been lower than expected reflecting power and third-party outages and slower execution of the well intervention program

§ Multiple production adding projects across our assets continue to be developed and implemented, underpinning full year guidance

Effective liquidity management

§ Hedged c.9.0 MMbbls of oil for 2021 with an average floor price of c.$59/bbl and an average ceiling price of $68/bbl 

§ Refinancing of the senior credit facility as part of the proposed Golden Eagle acquisition is on track

No change to guidance

§ 2021 average net Group production is expected to be between 46,000 Boepd and 52,000 Boepd; Kraken gross production is expected to be between 30,000 Bopd and 35,000 Bopd (21,150 Bopd to 24,675 Bopd net)

§ Operating expenditure is expected to be approximately $265 million

§ Combined cash capital and abandonment expenditure is expected to be approximately $120 million

§ Signed agreement to acquire non-operating interest in Golden Eagle; expected to complete around the end of the third quarter

§ Signed agreement to purchase the Bentley discovery

 

 

Production details

Average daily production on a net working interest basis (Boepd)

 

1 Jan 2021 to30 Apr 2021

1 Jan 2020 to30 Apr 2020

 

 

(Boepd)

(Boepd)

UK Upstream

 

 

 

 

- Magnus

 

14,250

18,330

- Kraken

 

22,689

26,871

- Other Upstream1

 

4,080

8,047

UK Upstream

 

41,019

53,238

UK Decommissioning2

 

508

4,111

Total UK

 

41,527

57,359

Total Malaysia

 

4,631

8,579

Total EnQuest

 

46,158

65,938

 

1 Other Upstream: Scolty/Crathes, Greater Kittiwake Area and Alba

2 UK Decommissioning: Heather/Broom, Thistle/Deveron, the Dons, Alma/Galia

 

Magnus

Average production for the first four months of 2021 was 14,250 Boepd, reflecting an unplanned third-party outage and power related failures in the first quarter, which have been rectified, and slower execution of the well intervention program. The Group remains focused on improving production through a well intervention programme, increased water injection and facility optimisation.

Kraken

During the first four months of 2021, average gross production was 32,183 Bopd, in line with 2021 full year guidance of between 30,000 and 35,000 Bopd (21,150 and 24,675 Bopd net). The floating, production, storage and offloading vessel continues to perform well, with production efficiency of 86% and water injection efficiency of 89%. A tether was successfully replaced in March, with the field shut in for approximately three days. Subsurface and well performance remains good, with aggregate water cut stable.

Other upstream assets

Production for the first four months of 2021 averaged 4,080 Boepd, in line with expectations. This was driven by good performance from Scolty/Crathes, reflecting the positive impact of compression uptime and gas lift, partially offset by lower production at the Greater Kittiwake Area, primarily as a result of a failure of an umbilical providing power to the Mallard and Gadwall wells impacting production. Reinstatement of power is expected in the third quarter of 2021.

Alba continues to perform broadly in line with Group expectations.

Midstream1

The Sullom Voe Terminal and its related infrastructure continues to maintain safe and reliable performance, with 100% export service availability during the first four months of 2021.

1 Includes the Sullom Voe Terminal and Pipelines

UK Decommissioning

Average production of 508 Boepd was lower than in 2020, primarily reflecting the cessation of production at Alma/Galia in June 2020 and the Dons in the first quarter of 2021, which together contributed c.4,000 Boepd during the first four months of 2020. In April, the Northern Producer Floating Production Facility departed the Dons and was handed back to its owners.

Malaysian operations

For the first four months of 2021, average production in Malaysia was 4,631 Boepd. Production has been better than expected as a result of the acceleration of initial production recovery activities following the riser detachment in late 2020. The Group anticipates replacement of the pipeline and riser around the end of the third quarter.

Business development 

In February, the Group signed an agreement with Suncor to purchase Suncor's entire 26.69% non-operated equity interest in the Golden Eagle area, comprising the producing Golden Eagle, Peregrine and Solitaire fields for an initial consideration of $325 million. Upon completion, expected to complete around the end of the third quarter, the agreement will add immediate incremental production of c.10 kboepd1, c.18 MMbbls to net 2P reserves1 and c.5MMbbls to net 2C resources1, in addition to providing significant medium term development potential and value enhancement.

In April, a share purchase agreement was signed with Whalsay Energy to purchase its entire 100.00% equity interest in the P1078 licence containing the proven Bentley heavy-oil discovery. The agreement is subject to a number of conditions precedent, including regulatory approval of the licence extension. This discovery is within c.15 kilometres of the Group's existing Kraken and Bressay operated interests, offering further long-term potential development opportunities and other synergies.

The Group also signed an agreement with Anasuria Hibiscus to farm-down an 85% working interest in, and transfer operatorship of, the Eagle discovery located in the UK North Sea. EnQuest will retain a 15% non-operating working interest.

1 EnQuest estimates

COVID-19 Update

The health, safety and wellbeing of our employees is our top priority. The Group remains compliant with UK, Malaysia and Dubai government and industry policy. The Group continues to work with a variety of stakeholders to ensure its operational response and advice to its workforce is appropriate and commensurate with the prevailing expert advice and level of risk. The Group's day-to-day operations continue without being materially affected by COVID-19.

2021 outlook (based on the Group's existing portfolio)

The Group remains on track with net production expected to be between 46,000 and 52,000 Boepd, with a number of production enhancing projects planned at several of the Group's assets through 2021, including the pipeline and riser re-instatement at PM8/Seligi in the second half of the year.

Operating expenditures are expected to be approximately $265 million and combined cash capital and abandonment expenditure is expected to be around $120 million.

EnQuest has hedged a total of c.9.0 MMbbls for 2021 predominantly using costless collars, with an average floor price of c.$59/bbl and an average ceiling price of c.$68/bbl. As at the end of April, c.6.2 MMbbls of production has been hedged with an average floor price of c.$63/bbl and an average ceiling price of c.$72/bbl.

 

EnQuest expects to announce its 2021 half year results on 2 September 2021.

Ends

 

For further information please contact:

 

EnQuest PLC

Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

 

Jonathan Swinney (Chief Financial Officer)

 

Ian Wood (Head of Communications & Investor Relations)

 

Jonathan Edwards (Senior Investor Relations & Communications Manager)

 

 

 

Tulchan Communications

Tel: +44 (0)20 7353 4200

Martin Robinson

 

Martin Pengelley

 

Harry Cameron

 

 

Notes to editors

 

ENQUEST

EnQuest is providing creative solutions through the energy transition. As an independent production and development company with operations in the UK North Sea and Malaysia, the Group's strategic vision is to be the operator of choice for maturing and underdeveloped hydrocarbon assets by focusing on operational excellence, differential capability, value enhancement and financial discipline.

EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm.

Please visit our website www.enquest.com for more information on our global operations.

Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectations and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share performance cannot be relied upon as a guide to future performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGPUUGAUPGPGG
Date   Source Headline
25th Feb 20217:00 amRNSEagle discovery farm-down
23rd Feb 202111:41 amRNSHolding(s) in Company
22nd Feb 20219:00 amRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
18th Feb 20213:09 pmRNSAdmission to trading
18th Feb 20219:00 amRNSHolding(s) in Company
9th Feb 202110:00 amRNSHolding(s) in Company
5th Feb 20212:49 pmRNSHolding(s) in Company
4th Feb 20215:52 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSOperations update
4th Feb 20217:00 amRNSAgreement to acquire UKNS asset
3rd Feb 20212:45 pmRNSHolding(s) in Company
3rd Feb 20218:30 amRNSDirectorate Change
29th Jan 20219:12 amRNSBond PIK Announcement
21st Jan 20217:00 amRNSAcquisition
11th Jan 20212:12 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:00 amRNSOperations update
23rd Oct 20208:56 amRNSBoard Appointment
15th Oct 20209:19 amRNSMaturity date extension: High Yield & Retail Notes
17th Sep 202010:07 amRNSDirector/PDMR Shareholding
14th Sep 20209:22 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSEnQuest PLC Half Year Results 2020
20th Aug 202011:14 amRNSAdmission to Trading
31st Jul 20207:00 amRNSEnQuest signs sale and purchase agreement
30th Jul 202010:37 amRNSBond PIK Announcement
29th Jun 20202:11 pmRNSPayments to governments
9th Jun 202012:20 pmRNSDirector/PDMR Shareholding
21st May 20204:20 pmRNSAGM Statement
21st May 20207:00 amRNSOperations update
4th May 202010:22 amRNSDirector/PDMR Shareholding
1st May 20204:26 pmRNSHolding(s) in Company
27th Apr 202010:52 amRNSDirector/PDMR Shareholding
24th Apr 20209:23 amRNSDirector/PDMR Shareholding
23rd Apr 20204:06 pmRNSNotice of AGM and Report & Accounts
21st Apr 202010:31 amRNSDirector/PDMR Shareholding
20th Apr 20203:25 pmRNSDirector/PDMR Shareholding
20th Apr 20202:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSEnQuest 2019 Full Year Results
8th Apr 20208:00 amRNSNotification of full year results announcement
2nd Apr 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20202:57 pmRNSFull year results update
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.